E2F4 Mediates Mitophagy to Inhibit Ferroptosis in Esophageal Cancer Cells by Activating GPR176
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Human Mutation
- Vol. 2026 (1) , 9418012
Abstract
Esophageal cancer (EC) is driven by complex dysregulated molecular networks, and ferroptosis—an iron‐dependent, non‐apoptotic form of regulated cell death—has emerged as a critical modulator of tumorigenesis. However, the functional contribution and mechanistic basis of GPR176 in ferroptosis regulation during EC progression remain largely unexplored. Here, we integrated computational and experimental approaches to delineate the role of GPR176 and its upstream regulator E2F4 in EC ferroptosis. Bioinformatic analysis revealed consistent upregulation of both GPR176 and E2F4 in EC tissues, which was further confirmed by molecular validation. Functional assays demonstrated that GPR176 overexpression conferred resistance to ferroptosis in EC cells, as reflected by reduced malondialdehyde, intracellular Fe 2+ , and lipid reactive oxygen species (ROS) accumulation, alongside altered expression of core ferroptosis mediators. This protective effect was associated with the suppression of mitophagy, as indicated by alterations in mitochondrial function and autophagy‐related markers. Mechanistically, we demonstrated that E2F4 directly binds to the GPR176 promoter and transcriptionally activates its expression. Rescue experiments further validated that GPR176 overexpression abrogated the enhanced mitophagy and ferroptosis induced by E2F4 depletion. Collectively, our findings define an E2F4/GPR176/mitophagy axis that acts to suppress ferroptosis in EC, highlighting this pathway as a novel therapeutic target for inducing ferroptosis in EC intervention.Keywords
This publication has 33 references indexed in Scilit:
- MTCH2 Deficiency Promotes E2F4/TFRC‐Mediated Ferroptosis and Sensitizes Colorectal Cancer Liver Metastasis to SorafenibAdvanced Science, 2025
- Pharmacological Activation of GPR68 Attenuates Ferroptosis in Spinal Cord Ischemia/Reperfusion Injury Through PI3K/Akt-Mediated Nrf2 Antioxidant PathwayInflammation, 2025
- Current status and perspectives of esophageal cancer: a comprehensive reviewCancer Communications, 2024
- GPR37 promotes colorectal cancer against ferroptosis by reprogramming lipid metabolism via p38-SCD1 axisApoptosis, 2024
- Mitophagy in health and disease. Molecular mechanisms, regulatory pathways, and therapeutic implicationsApoptosis, 2024
- Treatment strategy for early-stage esophageal cancerJapanese Journal of Radiology, 2024
- The promoting effects of GPR176 expression on proliferation, chemoresistance, lipogenesis and invasion of oesophageal cancerJournal of Cancer Research and Clinical Oncology, 2023
- Oncogenic roles of GPR176 in breast cancer: a potential marker of aggressiveness and a potential target of gene therapyClinical and Translational Oncology, 2023
- GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal CancerAdvanced Science, 2023
- E2F4 may be a core transcription factor in the lncRNA‐TF regulatory network in cervical cancerJournal of Clinical Laboratory Analysis, 2022